RECK/GPR124 ‐driven WNT signaling in pancreatic and gastric cancer cells
Cancer Science · 2024-09 · 115 (9) · 3013-3025
DOI: 10.1111/cas.16258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 26.06.2024. Verfasst von Hai Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan. Hauptthemen laut MEDLINE: GPI-Linked Proteins, Receptors, G-Protein-Coupled, Pancreatic Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
RECK has been described to modulate extracellular matrix components through negative regulation of MMP activities. Recently, RECK was demonstrated to bind to an orphan G protein‐coupled receptor GPR124 to mediate WNT7 signaling in nontumor contexts. Here, we attempted to clarify the role of RECK in driving WNT signaling in cancer cells. RECK and GPR124 formed a complex in 293T cells, and when both were expressed, WNT signaling was significantly enhanced in a WNT7‐dependent manner. This cooperation was abolished when RECK mutants unable to bind to GPR124 were transduced. RECK stimulated the growth of KRAS‐mutated pancreatic ductal adenocarcinoma (PDAC) cells with increased sensitivity to WNT inhibitor in a GPR124‐dependent manner. A gastric cancer cell line SH10TC endogenously expresses both RECK and GPR124 under regular culture conditions. In this cell line, inhibited cell growth and WNT signaling as well as increased apoptosis in the GPR124 depletion was dominantly found over those in the RECK deletion. These findings suggest that RECK promotes tumor cell growth by positively modulating WNT signaling through GPR124. This study proposes that the RECK/GPR124 complex might be a good therapeutic target in PDAC and gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
- Institute for Frontier Sciences Initiative, Kanazawa University, Kanazawa, Ishikawa, Japan.
- DNAFORM Precision Gene Technologies, Yokohama, Kanagawa, Japan.
ORCID-Profile: Susumu Kohno, Dominic Chih-Cheng Voon, Chiaki Takahashi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yu, H., Kohno, S., Voon, D. C., Hussein, N. H., Zhang, Y., Nakayama, J., Takegami, Y., & Takahashi, C. (2024). RECK/GPR124 ‐driven WNT signaling in pancreatic and gastric cancer cells. Cancer Science, 115(9), 3013-3025. https://doi.org/10.1111/cas.16258
Vancouver
Yu H, Kohno S, Voon DC, Hussein NH, Zhang Y, Nakayama J, et al. RECK/GPR124 ‐driven WNT signaling in pancreatic and gastric cancer cells. Cancer Science. 2024;115(9):3013-3025. doi:10.1111/cas.16258
BibTeX
@article{Yu2024,
author = {Yu, Hai and Kohno, Susumu and Voon, Dominic Chih-Cheng and Hussein, Nada Hamdy and Zhang, Yuanyuan and Nakayama, Joji and Takegami, Yujiro and Takahashi, Chiaki},
title = {RECK/GPR124 ‐driven WNT signaling in pancreatic and gastric cancer cells},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {9},
pages = {3013--3025},
doi = {10.1111/cas.16258}
}
EUVIMED